| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/26/2001 | US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress |
| 07/26/2001 | US20010009910 Administering calcium antagonist and reducing calcium pyrophosphate crystal deposition in an animal with pyrophosphate gout or osteoarthritis; diltiazem, nifedipine |
| 07/26/2001 | US20010009679 Fat soluble vitamin dispersed in a matrix of an emulsion-forming natural polysaccharide gum and/or a protein; beverages, tablets, cosmetics; powder in form of nanoparticles |
| 07/26/2001 | US20010009677 Sterol esters in tableted solid dosage forms |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | DE10001172A1 Templatieren von Feststoffpartikeln mit Polymermultischichten Templating of solid particles with polymer multilayers |
| 07/26/2001 | CA2673615A1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397802A1 Calcilytic compounds |
| 07/26/2001 | CA2397792A1 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397659A1 Statin-type bone growth stimulators |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2397531A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | CA2397492A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | CA2397065A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396908A1 Benzimidazole derivative |
| 07/26/2001 | CA2396697A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | CA2396319A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | CA2396307A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365118A1 Inhibitor against human chymase activity |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/25/2001 | EP1118680A1 Method for the diagnosis of polymorphisms in the human PDH E1alpha gene |
| 07/25/2001 | EP1118678A1 Method for diagnosing polymorphisms in the human PDH E1 beta gene |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117764A1 Primate embryonic stem cells with compatible histocompatibility genes |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117692A1 Tie2 agonist antibodies |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117676A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117662A1 Benzimidazolinyl piperidines as cgrp ligands |
| 07/25/2001 | EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 07/25/2001 | EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 07/25/2001 | EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117429A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117412A1 Compositions containing diphosphonic acids |
| 07/25/2001 | EP1117411A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117392A1 Method for preventing or delaying catheter-based revascularization |
| 07/25/2001 | EP0889876B1 Meta-substituted phenylene sulphonamide derivatives |
| 07/25/2001 | EP0788362B1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 07/25/2001 | EP0741709B1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305474A Paroxetine maleate |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1304751A Scrophularia capsule and its preparing process |
| 07/25/2001 | CN1304736A Medicine for treating diabetes nerve end inflammation |
| 07/25/2001 | CN1304728A Soft yolk oil capsule |
| 07/25/2001 | CN1304687A Se-enriched cordyceps militaris tea and its preparing process |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265544 Adipocyte-specific protein homologs |
| 07/24/2001 | US6265450 Administering astexanthin |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265431 Cycloalkano-indole and -azaindole derivatives |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265403 Angiogenesis inhibitors |
| 07/24/2001 | US6265401 Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/24/2001 | US6265399 Alkylation; cyclization |
| 07/24/2001 | US6265377 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/24/2001 | US6264986 Emulsification, mixing, drying |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264938 Administering polydiallylamine and hydroxy-3-methylglutaryl/3-/, coenzyme a reductase |
| 07/24/2001 | CA2331847A1 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2042112C N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 07/24/2001 | CA2026540C Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions |
| 07/24/2001 | CA2024629C Xenopus laevis bone morphogenic protein, dna encoding same and use thereof |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051492A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |